Evidence map›Paper›PMID 28808943›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

A logistic regression model predicting high axillary tumour burden in early breast cancer patients.

I Barco, M García Font, A García-Fernández, N Giménez, M Fraile, J M Lain, E Vallejo, S González, L Canales, J Deu and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

I BarcoBreast Unit, Department of Gynecology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain. ibarco@mutuaterrassa.es.ORCID http://orcid.org/0000-0003-3520-8736
M García FontUniversity International of Catalunya, Barcelona, Spain.
A García-FernándezBreast Unit, Department of Gynecology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
N GiménezResearch Unit, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
M FraileNuclear Medicine Department, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
J M LainBreast Unit, Department of Gynecology, Hospital of Terrassa, Health Consortium of Terrassa, Terrassa, Spain.
E VallejoBreast Unit, Department of Gynecology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
S GonzálezDepartment of Oncology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
L CanalesDepartment of Radiology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
J DeuBreast Unit, Department of Gynecology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
M C VidalDepartment of Nursing, Institut Catala de la Salut, Barcelona, Spain.
M Rodríguez-CarballeiraDepartment of Internal Medicine, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
A PessarrodonaBreast Unit, Department of Gynecology, University Hospital of MútuaTerrassa, Research Foundation MútuaTerrassa, University of Barcelona, Barcelona, Spain.
C ChabreraDepartment of Nursing, School of Health Science, TecnoCampusMataró-Maresme, Barcelona, Spain.
University Hospital Mútua de Terrassa · ESHospital Terrassa · ESInstitut Català de la Salut · ESMaresme Health Consortium · ESUniversitat Autònoma de Barcelona · ESUniversitat Internacional de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs elective axillary dissection is loosing ground for early breast cancer (BC) patients both in terms of prognostic and therapeutic power, there is a growing interest in predicting patients with (nodal) high tumour burden (HTB), especially after a positive sentinel node biopsy (SNB) because they would really benefit from further axillary intervention either by complete lymph-node dissection or axillary radiation therapy. METHODS/PATIENTS: Based on an analysis of 1254 BC patients in whom complete axillary clearance was performed, we devised a logistic regression (LR) model to predict those with HTB, as defined by the presence of three or more involved nodes with macrometastasis. This was accomplished through prior selection of every variable associated with HTB at univariate analysis.

resultsOnly those variables shown as significant at the multivariate analysis were finally considered, namely tumour size, lymphovascular invasion and histological grade. A probability table was then built to calculate the chances of HTB from a cross-correlation of those three variables. As a suggestion, if we were to follow the rationale previously used in the micrometastasis trials, a threshold of about 10% risk of HTB could be considered under which no further axillary treatment is warranted.

conclusionsOur LR model with its probability table can be used to define a subgroup of early BC patients suitable for axillary conservative procedures, either sparing completion lymph-node dissection or even SNB altogether.

Indexed as

Logistic ModelsAgedAxillaBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularFemaleFollow-Up StudiesHumansLymph Node ExcisionLymph NodesMiddle AgedNeoplasm InvasivenessNeoplasm MicrometastasisNeoplasm StagingSentinel Lymph Node BiopsyAxillaBreast neoplasmsMortalitySentinel lymph node biopsySurvivalTumour burden

Identifiers

PMID28808943
OpenAlexW2747429409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.